Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
6
×
national blog main
takeda pharmaceutical
6
×
boston top stories
cancer
deals
fda
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
covid-19
eli lilly
europe blog main
europe top stories
What
bio
roundup
acquisitions
buy
ceo
company’s
daniel
gilead
growing
help
ipo
medicines
o’day
pipeline
sciences
alliance
analytics
announced
bails
biggest
biofourmis
brand
bridgebio
bristol
build
calls
capital
car
changing
collabs
color
course
covid
crispr
data
days
deal
debut
develop
development
Language
unset
6
×
Current search:
unset
×
" takeda pharmaceutical "
×
" life sciences "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More